Risk of perioperative mortality and venous thromboembolism after total hip or knee arthroplasty with recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database
- PMID: 40961375
- PMCID: PMC12444792
- DOI: 10.2340/17453674.2025.44481
Risk of perioperative mortality and venous thromboembolism after total hip or knee arthroplasty with recent COVID-19 infection: an observational study from the Kaiser Permanente Northern California Database
Abstract
Background and purpose: Limited data exist on venous thromboembolism (VTE) and mortality risk in patients undergoing primary total hip (THA) or knee arthroplasty (TKA) following recent COVID-19 infection. We aimed to evaluate whether the timing of COVID-19 infection affects postoperative VTE and mortality risk after THA or TKA.
Methods: Adult Kaiser Permanente Northern California members undergoing elective THA or TKA from 2020-2022 were identified using internal procedure codes. 33,520 patients with or without SARS-CoV-2 within 6 months preoperatively were compared. Multivariate Poisson regression was used to calculate incidence rate ratios (RRs) adjusted for demographics, comorbidities, and Covid vaccination status. The primary outcome was 90-day VTE (deep venous thrombosis or pulmonary embolism). The secondary outcome was 90-day mortality.
Results: Among patients with recent COVID-19, the 90-day VTE rate was 0.3%, and the mortality rate was 2.5%. Recent COVID-19 within 6 to 12 weeks preoperatively did not significantly increase 90-day VTE risk (RR 1.0, 95% confidence interval [CI] 0.38-2.8) but was associated with increased 90-day mortality risk (RR 3.1, CI 1.7-5.4).
Conclusion: Recent COVID-19 infection did not significantly impact VTE risk after THA or TKA. However, infection within 6 to 12 weeks preoperatively was associated with increased 90-day mortality.
Conflict of interest statement
This study was conducted under approval by the Kaiser Permanente Northern California Institutional Review Board (approval #2056765). Data sharing is not possible due to existing regulation; however, requests for sub-analyses may be considered. This study was funded internally through the Kaiser Delivery Science and Applied Research Unit. Study funding did not influence the interpretation of data, reporting of results, writing of the manuscript, or decision to publish. Each author certifies that he or she has no commercial associations that might pose a conflict of interest in connection with the submitted article. Complete disclosure of interest forms according to ICMJE are available on the article page:
References
-
- U.S. Centers for Disease Control & Infection. About Covid-19. Accessed 2025, Jan 29. https://www.cdc.gov/covid/about/index.html
-
- World Health Organization. Covid-19 Dashboard – Cases. Accessed 2025, Jan 29. https://data.who.int/dashboards/covid19/cases
-
- Agency for Healthcare Research and Quality. Hcup fast stats – most common operations during inpatient stays. Accessed 2025, Jan 29. https://datatools.ahrq.gov/hcup-fast-stats/
-
- Anderson D R, Morgano G P, Bennett C, Dentali F, Francis C W, Garcia D A, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 2019; 3(23): 3898-944. doi: 10.1182/bloodadvances.2019000975. - DOI - PMC - PubMed
-
- Bawa H, Weick J W, Dirschl D R, Luu H H. Trends in deep vein thrombosis prophylaxis and deep vein thrombosis rates after total hip and knee arthroplasty. J Am Acad Orthop Surg 2018; 26(19): 698-705. doi: 10.5435/JAAOS-D-17-00235. Erratum in: J Am Acad Orthop Surg 2018; 26(23): 852. doi: 10.5435/JAAOS-D-18-00635. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Medical